Advances in Surgical Techniques for Gastroparesis

Introduction

It is called gastroparesis when the stomach takes too long to empty its contents. Gastroparesis symptoms are bloating, vomiting, nausea, and abdominal pain. Numerous conditions, including diabetes, surgery, and idiopathic causes, are the causative factors for this condition. Dietary adjustments and drugs such as prokinetics and, in more extreme situations, surgery such as pyloromyotomy(surgery to treat pyloric stenosis) or gastric electrical stimulation are all part of the treatment. Diabetes is a common condition along with gastroparesis, which affects almost fifty percent of the individuals with a long-lasting disease. Long-term care may be necessary to reduce symptoms and enhance quality of life if the illness is chronic. Gastroparesis self-care is essential, as well as avoiding carbonated drinks. Diabetes affects the vagus nerve, affects the digestion process, and leads to diabetic gastroparesis.

What Are the Advances in Surgical Techniques for Gastroparesis?

Some patients with gastroparesis may experience symptoms that are too severe for them to control with dietary modifications and medication. Disabling symptoms can drastically lower a person's quality of life. Refractory symptoms, or persistent symptoms that do not go away, can occasionally lead to hospitalizations for malnutrition, electrolyte imbalances, and potentially fatal dehydration. Further management-enhancing treatment options are as follows:

• Enteral nutrition.

• Parenteral nutrition.

• Gastric electrical stimulation.

• Other surgical procedures.

Enteral Nutrition:

A feeding tube inserts liquid food into the digestive tract during enteral nutrition. When oral eating is insufficient to provide enough nourishment, it is utilized. A surgeon, radiology team, or endoscopy specialist may implant a tube into the stomach and small intestine in cases of more severe gastroparesis. The term gastrostomy-jejunostomy (G/J tube) describes this particular tube. In individuals with delayed stomach emptying, such as those with gastroparesis, the tube can help avoid the stomach by being inserted into the small intestine. A 6 to 12-inch tube protrudes from the stomach or small intestine to facilitate feeding nutritious formula foods and drugs through the tube. This is handled with the assistance of a dietician and healthcare provider.

Parenteral Nutrition:

When oral and tube feeding are not feasible due to severe gastroparesis, an intravenous (IV) catheter may be inserted to deliver nutrients while circumventing the gastrointestinal tract. This is known as a PICC line and is often inserted into the arm. A tiny, flexible tube called an IV catheter is inserted into a vein. A specifically designed formula inserted into the catheter provides nutrition that the body does not need to digest, enabling the body to absorb nutrients straight into the circulation.

G-POEM:

A surgeon slices the pyloric muscle during a gastric peroral endoscopic myotomy (G-POEM) to allow the pyloric muscle to open. This technique, carried out by an accomplished endoscopist or surgeon, may benefit some patients with improved stomach emptying.

Gastric Electrical Stimulation (GES):

A tiny gadget is surgically placed beneath the skin in the lower abdomen to treat a subset of GP patients who may not be responding to standard GP treatments. GES has been demonstrated to reduce nausea and vomiting frequency, although it does not affect gastric emptying. Enterra therapy has FDA(Food and Drug Administration) approval owing to an exemption for humanitarian uses. The gadget can be inserted laparoscopically, reducing the possibility of surgical complications. The battery-operated gadget can be implanted, and its settings can be modified to find the optimal setting for controlling symptoms. Enterra II, a second-generation device, received FDA approval in 2015 after initial approval in 2000. The more recent gadget offers doctors more system flexibility and user-friendliness. It is necessary to continue with different treatment modalities because Enterra therapy is not a cure. If the therapy is ineffective, the gadget can be taken out.

What Are the Other Surgical Procedures for Gastroparesis?

Other gastroparesis surgeries are as follows:

• A gastrostomy (a stomach tube) venting may help treat severe nausea and vomiting by preventing extra air and fluid accumulation in the stomach.

• Attempts to aid in stomach emptying include pyloroplasty (a surgery to expand the lower portion of the stomach) and gastrojejunostomy (a surgical operation that joins the stomach to the jejunum portion of the small intestine).

• A gastrectomy is the surgical excision of all or a portion of the stomach. Investigations continue into how well these techniques work in treating gastroparesis.

• In pacemaker gastroparesis surgery, an incision is made in the lower abdomen. A tiny, battery-powered gadget known as a stomach stimulator is carefully positioned beneath the abdominal skin. A pair of wires, or leads, are fastened to a certain spot on the stomach wall to link the gadget, sealing off the wound.

• After all other options have been thoroughly discussed and reviewed, these operations should only be considered in carefully chosen patients with unique needs and circumstances.

• Other gastroparesis medications include Metoclopramide, Erythromycin, and Domperidone.

What Is Humanitarian Use Device Exemption?

• The U.S. Food and Drug Administration (FDA) has certified the Enterra therapy system as a humanitarian device for treating chronic nausea and vomiting associated with gastroparesis by gastric electrical stimulation. Congress established the Humanitarian Use Device (HUD) process, a unique procedure the FDA uses to develop therapies for communities affected by uncommon diseases. A Humanitarian Device Exemption (HDE) is granted to devices that have undergone review and approval through this process.

• Even though the FDA has evaluated and authorized these devices, many insurance companies will not pay for the treatments because they were not approved through the normal process, therefore classifying them as "investigational." In certain situations, patient access may be severely restricted due to the treatment's cost alone. Even though Enterra is not for everyone, some people can recover and have productive lives after using it. It is necessary to address the possibility that those pursuing Enterra or other advantageous rare disease medicines will have access to these treatments disallowed by a third-party payer.

Conclusion

Managing gastroparesis is a challenging disease. Gastroparesis diet consists of simple digestive foods like bananas, smooth peanut butter, and eggs. In gastroparesis, life expectancy is not reduced. In the end, a gastrectomy can be required to manage symptoms and enhance the quality of life for patients. However, this last resort should only be considered when all other organ-saving alternatives have been exhausted. Although there is not a single therapeutic option that works for everyone, in cases of refractory gastroparesis, a partial gastrectomy combined with a Roux-en-Y gastrojejunostomy is considered a final resort. Ideally, this should be done at a busy facility with the know-how to handle many surgical problems. Given the potential necessity for a full gastrectomy, a Roux-en-Y gastrojejunostomy that leaves the stomach in situ is a suitable alternative.